SEARCH

SEARCH BY CITATION

References

  • 1
    Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E. et al., Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001. 27: 6873.
  • 2
    Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E. et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001. 27: 2021.
  • 3
    Roncarolo, M. G. and Battaglia, M., Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007. 7: 585598.
  • 4
    Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., Defor, T. et al., Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011. 117: 10611070.
  • 5
    Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B. et al., Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011. 117: 39213928.
  • 6
    Tarbell, K. V., Petit, L., Zuo, X., Toy, P., Luo, X., Mqadmi, A., Yang, H. et al., Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 2007. 204: 191201.
  • 7
    Tang, Q., Henriksen, K. J., Bi, M., Finger, E. B., Szot, G., Ye, J., Masteller, E. L. et al., In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004. 199: 14551465.
  • 8
    Stephens, L. A., Malpass, K. H. and Anderton, S. M., Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 2009. 39: 11081117.
  • 9
    Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., Witteveen, H. J., van Ewijk, W., van Laar, J. M., de Vries, R. R. et al., Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 2005. 52: 22122221.
  • 10
    Nguyen, T. L., Sullivan, N. L., Ebel, M., Teague, R. M. and Dipaolo, R. J., Antigen-specific TGF-{beta}-induced regulatory T cells secrete chemokines, regulate T cell trafficking, and suppress ongoing autoimmunity. J. Immunol. 2011. 187(4): 17451753.
  • 11
    Suri-Payer, E., Kehn, P. J., Cheever, A. W. and Shevach, E. M., Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells. J. Immunol. 1996. 157: 17991805.
  • 12
    D'Elios, M. M., Bergman, M. P., Azzurri, A., Amedei, A., Benagiano, M., De Pont, J. J., Cianchi, F. et al., H(+),K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001. 120: 377386.
  • 13
    Suri-Payer, E., Amar, A. Z., McHugh, R., Natarajan, K., Margulies, D. H. and Shevach, E. M., Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur. J. Immunol. 1999. 29: 669677.
  • 14
    Callaghan, J. M., Khan, M. A., Alderuccio, F., van Driel, I. R., Gleeson, P. A. and Toh, B. H., Alpha and beta subunits of the gastric H+/K(+)-ATPase are concordantly targeted by parietal cell autoantibodies associated with autoimmune gastritis. Autoimmunity 1993. 16: 289295.
  • 15
    Toh, B. H., van Driel, I. R. and Gleeson, P. A., Pernicious anemia. N. Engl. J. Med. 1997. 337: 14411448.
  • 16
    Tu, E., Ang, D. K., Hogan, T. V., Read, S., Chia, C. P. Z., Gleeso, P. A. and van Driel, I. R., A convenient model of severe, high Incidence autoimmune gastritis caused by polyclonal effector T Cells and without perturbation of regulatory T cells. PLoS One 2011. 6: e27153.
  • 17
    Paliogianni, F., Ahuja, S. S., Balow, J. P., Balow, J. E. and Boumpas, D. T., Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 1993. 151: 40814089.
  • 18
    Vanderheyde, N., Verhasselt, V., Goldman, M. and Willems, F., Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 1999. 67: 13421347.
  • 19
    Jeffries, G. H., Todd, J. E. and Sleisenger, M. H., The effect of prednisolone on gastric mucosal histology, gastric secretion, and vitamin B 12 absorption in patients with pernicious anemia. J. Clin. Invest. 1966. 45: 803812.
  • 20
    Jeffries, G. H., Recovery of gastric mucosal structure and function in pernicious anemia during prednisolone therapy. Gastroenterology 1965. 48: 371378.
  • 21
    Biondo, M., Field, J., Toh, B. H. and Alderuccio, F., Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. J. Pathol. 2006. 209: 384391.
  • 22
    Chen, X., Oppenheim, J. J., Winkler-Pickett, R. T., Ortaldo, J. R. and Howard, O. M., Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 2006. 36: 21392149.
  • 23
    Braitch, M., Harikrishnan, S., Robins, R. A., Nichols, C., Fahey, A. J., Showe, L. and Constantinescu, C. S., Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol. Scand. 2009. 119: 239245.
  • 24
    Read, S., Hogan, T. V., Zwar, T. D., Gleeson, P. A. and Van Driel, I. R., Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells. Gastroenterology 2007. 133: 547558.
  • 25
    Holda, J. H. and Swanborg, R. H., Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats. Eur. J. Immunol. 1981. 11: 338340.
  • 26
    Judd, L. M., Gleeson, P. A., Toh, B. H. and van Driel, I. R., Autoimmune gastritis results in disruption of gastric epithelial cell development. Am. J. Physiol. 1999. 277: G209218.
  • 27
    Kang, W., Rathinavelu, S., Samuelson, L. C. and Merchant, J. L., Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab. Invest. 2005. 85: 702715.
  • 28
    Bettini, M. L., Pan, F., Bettini, M., Finkelstein, D., Rehg, J. E., Floess, S., Bell, B. D. et al., Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 2012. 36: 717730.
  • 29
    Darce, J., Rudra, D., Li, L., Nishio, J., Cipolletta, D., Rudensky, A. Y., Mathis, D. et al., An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 2012. 36: 731741.
  • 30
    Riley, J. L., June, C. H. and Blazar, B. R., Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity 2009. 30: 656665.
  • 31
    Golovina, T. N., Mikheeva, T., Brusko, T. M., Blazar, B. R., Bluestone, J. A. and Riley, J. L., Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells. PLoS One 2011. 6: e15868.
  • 32
    Wang, J., Huizinga, T. W. and Toes, R. E., De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid. J. Immunol. 2009. 183: 41194126.
  • 33
    McHugh, R. S., Shevach, E. M., Margulies, D. H. and Natarajan, K., A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur. J. Immunol. 2001. 31: 20942103.
  • 34
    Spicer, Z., Miller, M. L., Andringa, A., Riddle, T. M., Duffy, J. J., Doetschman, T. and Shull, G. E., Stomachs of mice lacking the gastric H,K-ATPase alpha -subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J. Biol. Chem. 2000. 275: 2155521565.
  • 35
    Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y., Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005. 22: 329341.
  • 36
    Alderuccio, F., Toh, B. H., Tan, S. S., Gleeson, P. A. and van Driel, I. R., An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J. Exp. Med. 1993. 178: 419426.